Marilyn Huckans

Summary

Country: USA

Publications

  1. pmc Efficacy of cognitive rehabilitation therapies for mild cognitive impairment (MCI) in older adults: working toward a theoretical model and evidence-based interventions
    Marilyn Huckans
    Research and Development Service, Portland VA Medical Center, 3710 SW U S Veterans Hospital Rd, Portland, OR 97239, USA
    Neuropsychol Rev 23:63-80. 2013
  2. ncbi request reprint A pilot study examining effects of group-based Cognitive Strategy Training treatment on self-reported cognitive problems, psychiatric symptoms, functioning, and compensatory strategy use in OIF/OEF combat veterans with persistent mild cognitive disorder a
    Marilyn Huckans
    Research Division, Portland VA Medical Center P3MHN, 3710 SW U S Veterans Hospital Rd, Portland, OR 97239, USA
    J Rehabil Res Dev 47:43-60. 2010
  3. pmc Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders
    Marilyn S Huckans
    Northwest Hepatitis C Resource Center, Portland VA Medical Center, Portland, USA
    Subst Abuse Treat Prev Policy 2:4. 2007
  4. pmc Discounting of delayed rewards and executive dysfunction in individuals infected with hepatitis C
    Marilyn Huckans
    Northwest Hepatitis C Resource Center, Portland VA Medical Center, Portland, OR 97239, USA
    J Clin Exp Neuropsychol 33:176-86. 2011
  5. pmc Antiviral therapy completion and response rates among hepatitis C patients with and without schizophrenia
    Marilyn Huckans
    Department of Psychiatry, Oregon Health and Science University, Portland, Oregon, USA
    Schizophr Bull 36:165-72. 2010
  6. pmc The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder
    Marilyn Huckans
    Northwest Hepatitis C Resource Center, Portland VA Medical Center, Portland, Oregon 97239, USA
    J Int Neuropsychol Soc 15:69-82. 2009
  7. pmc The influence of antiviral therapy on psychiatric symptoms among patients with hepatitis C and schizophrenia
    Marilyn Huckans
    Northwest Hepatitis C Resource Center, Portland VA Medical Center, Portland, OR, USA
    Antivir Ther 15:111-9. 2010
  8. doi request reprint Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study
    Jennifer M Loftis
    Research and Development Service, Portland VA Medical Center, Portland, OR, USA
    J Psychosom Res 74:57-63. 2013
  9. pmc Predictors of pain intensity and pain functioning in patients with the hepatitis C virus
    Benjamin J Morasco
    Northwest Hepatitis C Resource Center and Mental Health and Clinical Neurosciences Division, Portland VA Medical Center, Portland, OR 97239, USA
    Gen Hosp Psychiatry 32:413-8. 2010
  10. ncbi request reprint Protective effects of higher cognitive reserve for neuropsychological and daily functioning among individuals infected with hepatitis C
    Maiko Sakamoto
    Department of Psychiatry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA
    J Neurovirol 19:442-51. 2013

Collaborators

Detail Information

Publications18

  1. pmc Efficacy of cognitive rehabilitation therapies for mild cognitive impairment (MCI) in older adults: working toward a theoretical model and evidence-based interventions
    Marilyn Huckans
    Research and Development Service, Portland VA Medical Center, 3710 SW U S Veterans Hospital Rd, Portland, OR 97239, USA
    Neuropsychol Rev 23:63-80. 2013
    ..Overall, results from trials are promising but inconclusive. Additional well-designed and adequately powered trials are warranted and required before CRTs for MCI can be considered evidence-based...
  2. ncbi request reprint A pilot study examining effects of group-based Cognitive Strategy Training treatment on self-reported cognitive problems, psychiatric symptoms, functioning, and compensatory strategy use in OIF/OEF combat veterans with persistent mild cognitive disorder a
    Marilyn Huckans
    Research Division, Portland VA Medical Center P3MHN, 3710 SW U S Veterans Hospital Rd, Portland, OR 97239, USA
    J Rehabil Res Dev 47:43-60. 2010
    ..Group-based CST is a promising intervention for veterans with mild cognitive disorder, and randomized controlled trials are required to further evaluate its efficacy...
  3. pmc Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders
    Marilyn S Huckans
    Northwest Hepatitis C Resource Center, Portland VA Medical Center, Portland, USA
    Subst Abuse Treat Prev Policy 2:4. 2007
    ....
  4. pmc Discounting of delayed rewards and executive dysfunction in individuals infected with hepatitis C
    Marilyn Huckans
    Northwest Hepatitis C Resource Center, Portland VA Medical Center, Portland, OR 97239, USA
    J Clin Exp Neuropsychol 33:176-86. 2011
    ....
  5. pmc Antiviral therapy completion and response rates among hepatitis C patients with and without schizophrenia
    Marilyn Huckans
    Department of Psychiatry, Oregon Health and Science University, Portland, Oregon, USA
    Schizophr Bull 36:165-72. 2010
    ..Despite disproportionately high rates of hepatitis C (HCV) among patients with severe mental illness, to date, there is scant empirical data available regarding antiviral therapy outcomes within this population...
  6. pmc The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder
    Marilyn Huckans
    Northwest Hepatitis C Resource Center, Portland VA Medical Center, Portland, Oregon 97239, USA
    J Int Neuropsychol Soc 15:69-82. 2009
    ..Results indicate that chronic HCV is associated with cognitive impairment in the absence of a history of SUD. The most robust deficits appear to be in verbal learning and reasoning/mental flexibility. (JINS, 2009, 15, 69-82.)...
  7. pmc The influence of antiviral therapy on psychiatric symptoms among patients with hepatitis C and schizophrenia
    Marilyn Huckans
    Northwest Hepatitis C Resource Center, Portland VA Medical Center, Portland, OR, USA
    Antivir Ther 15:111-9. 2010
    ..The aim of this study was to determine whether antiviral therapy is associated with higher rates of psychiatric symptoms in patients with schizophrenia (SCHZ)...
  8. doi request reprint Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study
    Jennifer M Loftis
    Research and Development Service, Portland VA Medical Center, Portland, OR, USA
    J Psychosom Res 74:57-63. 2013
    ..e., cognitive-affective and somatic) in Veterans with hepatitis C viral infection (HCV) before and during interferon-alpha (IFN) based antiviral therapy...
  9. pmc Predictors of pain intensity and pain functioning in patients with the hepatitis C virus
    Benjamin J Morasco
    Northwest Hepatitis C Resource Center and Mental Health and Clinical Neurosciences Division, Portland VA Medical Center, Portland, OR 97239, USA
    Gen Hosp Psychiatry 32:413-8. 2010
    ..To examine the relationships among biological and psychological variables with pain intensity and pain functioning in patients with the hepatitis C virus (HCV)...
  10. ncbi request reprint Protective effects of higher cognitive reserve for neuropsychological and daily functioning among individuals infected with hepatitis C
    Maiko Sakamoto
    Department of Psychiatry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA
    J Neurovirol 19:442-51. 2013
    ..Findings indicate that higher levels of CR may be a protective factor in the neurocognitive and real-world manifestation of neural injury commonly associated with HCV infection. ..
  11. pmc Partial MHC/neuroantigen peptide constructs: a potential neuroimmune-based treatment for methamphetamine addiction
    Jennifer M Loftis
    Research and Development, Portland VA Medical Center, Portland, Oregon, United States of America
    PLoS ONE 8:e56306. 2013
    ..Collectively, these initial results indicate that neuroimmune targeted therapies, and specifically RTL551, may have potential as treatments for methamphetamine-induced neuropsychiatric impairments...
  12. pmc Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha
    Jennifer M Loftis
    Behavioral Health and Clinical Neurosciences Division, Portland VA Medical Center, Department of Psychiatry, Oregon Health and Science University, Portland, OR 97239, USA
    Neurosci Lett 430:264-8. 2008
    ..Future studies should investigate how inflammatory mediators play a role in the expression of specific depressive symptoms in patients with chronic infection. Patients with HCV represent an interesting model to examine this relationship...
  13. doi request reprint Adipocytokine signaling is altered in Flinders sensitive line rats, and adiponectin correlates in humans with some symptoms of depression
    Clare J Wilhelm
    Research and Development Service, Portland Veterans Affairs Medical Center, Portland, OR 97239, United States
    Pharmacol Biochem Behav 103:643-51. 2013
    ....
  14. pmc Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies
    Jennifer M Loftis
    Research and Development Service, Behavioral Health and Clinical Neurosciences Division, Portland VA Medical Center, 3710 SW US Veterans Hospital Rd, Portland, OR 97239, USA
    Neurobiol Dis 37:519-33. 2010
    ..Future research should aim to characterize these depression-related symptom constellations or syndromes better with the goal of optimizing treatment strategies...
  15. doi request reprint Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders
    Annette M Matthews
    Northwest Hepatitis C Resource Center, and Behaviorual Health and Clinical Neurosciences Division, Portland VA Medical Center, Portland, OR 97202, USA
    Bipolar Disord 10:266-70. 2008
    ..Our hypothesis was that HCV antibody testing rates and HCV prevalence would be higher in the BD, SUD, and DD groups than the control group...
  16. ncbi request reprint Management of hepatitis C disease among VA patients with schizophrenia and substance use disorders
    Marilyn S Huckans
    Northwest Hepatitis C Resource Center, Portland Veterans Affairs Medical Center, and Department of Psychiatry at Oregon Health and Science University 97239, USA
    Psychiatr Serv 57:403-6. 2006
    ....
  17. ncbi request reprint Integrated hepatitis C virus treatment: addressing comorbid substance use disorders and HIV infection
    Marilyn S Huckans
    Northwest Hepatitis C Resource Center, Portland VA Medical Center, Portland, OR 97239, USA
    AIDS 19:S106-15. 2005
    ..To examine hepatitis C virus (HCV) and HIV testing patterns within the Northwest Veterans Integrated Service Network (VISN 20)...
  18. pmc Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy
    Jennifer M Loftis
    Research and Development Service, Portland VA Medical Center, Portland, OR, USA
    Pharmacol Ther 139:289-300. 2013
    ..Several novel therapeutic approaches that are currently under investigation are introduced; translational data from animal and human studies is presented, highlighting immunotherapy as a promising new direction for addiction medicine. ..